Test Price
2,800 AED✅ Home Collection Available
LIM2 Gene Cataract, Cortical Pulverulent, Late-Onset Genetic Test in Dubai | 2800 AED
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by Consultant Medical Genetics.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The LIM2 gene test identifies pathogenic variants associated with cortical pulverulent cataract, typically late-onset, using high-depth next-generation sequencing. This genetic analysis helps guide clinical management, familial risk assessment, and personalized ophthalmologic care.
| Feature | Our Test (DHA Ref. LIM2-NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – whole gene coverage including intronic regions | Sanger Sequencing – limited exon selection, may miss deep intronic variants |
| Diagnostic Sensitivity | 99.9% (ISO 9001:2015 validated) | 95–98% |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Sample Types | Whole Blood (EDTA), Extracted DNA, or FTA Card Spot | EDTA Blood or Purified DNA only |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I emphasize that LIM2 gene test results must be correlated with a thorough ophthalmologic examination and detailed three-generation family pedigree. Variants of uncertain significance require multidisciplinary discussion before clinical action. This genetic assay supplements—not replaces—standard ophthalmic surveillance and cataract surgery evaluation.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Critical Safety & Exclusion Advisory
- Exclusion Criteria: This test is not indicated for acute ophthalmic emergencies requiring immediate surgical intervention, individuals unable to provide informed consent, or sample collection from patients with severe coagulopathy without physician clearance.
- ER Red Flags: Sudden vision loss, severe eye pain, or ocular trauma demand immediate emergency care—genetic testing is inappropriate in these scenarios. Seek urgent ophthalmology evaluation.
Medication Advisory
Do not discontinue prescribed ophthalmic or systemic medications without consulting your treating physician. Genetic testing does not alter existing treatment plans without specialist review.
Patient FAQ & Clinical Guidance
1. What is the clinical utility of LIM2 gene testing?
This genetic test confirms LIM2 mutations causing cortical pulverulent cataract, guiding personalized treatment decisions, surgical timing, and familial risk assessment. Results enable accurate genetic counseling for at-risk relatives.
2. How is the test performed?
A peripheral blood sample, extracted DNA, or FTA card spot is collected. The specimen undergoes next‑generation sequencing targeting the full LIM2 gene, with results reported within 3–4 weeks.
3. Is genetic counseling required before testing?
Yes, pre‑test genetic counseling is mandatory to explain the implications of possible results, document a three-generation pedigree, obtain informed consent, and comply with UAE regulatory standards.
4. What samples are accepted and how do I arrange collection?
We accept EDTA whole blood, extracted DNA, or FTA card spots. A VIP mobile phlebotomist can visit your home daily from 8 AM to 11 PM for blood collection, using temperature-controlled cold-chain transport.
5. Can insurance cover this test?
Direct billing verification is available through our insurance team via WhatsApp at +971 54 548 8731. Coverage depends on your policy and medical necessity documentation.
UAE Regulatory & Data Privacy Adherence
- Data Privacy: All genetic data is processed in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Medical Liability: Clinical testing safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Laboratory Accreditation: ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139) with DHA facility licensing ensuring international quality standards.
Clinical & Logistical Metadata
| Test Name | LIM2 Gene Sequencing (Cortical Pulverulent Cataract, Late-Onset) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or FTA Card Spot |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full gene coverage including exon‑intron boundaries |
| ICD-10-CM Code | H25.8 |
| LOINC Code | 94494-6 |
| DHA Facility License & Address | DHA Facility License 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians